ParaZero Technologies To Provide Earnings Updates And REC-4881 Data As Well As KOL And Patient Panels On Tuesday, November 3, 2026
Recursion (NASDAQ:RXRX), a leading clinical-stage company pioneering AI-enabled drug discovery and development decoding biology to radically improve lives, announced today it will provide business updates and report its
Recursion will share earnings results and new drug study data Tuesday. Listen for what the company says about its progress and plans.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.